Mon.Jun 08, 2020

article thumbnail

From Dallas and Hesitant About Clinical Research

ECRG Media's Clinical Research Podcast

From Dallas and Hesitant About Clinical Research Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Sen

article thumbnail

Ep. 007 – Holly Henry and Kamran Shah Podcast Transcript

Pharma Marketing Network

RJ (PMN): Hi this is RJ Lewis, your host of the pharma marketing network podcast and I’m excited today to have with me a couple of executives from Klick Health to talk about CCPA. We have Holly Henry on the phone who is the chief medical officer of klick, and we also have Kamran Shah who is the EVP of technology and media. Welcome to the podcast!

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

From Dallas and Hesitant About Clinical Research

ECRG Media's Clinical Research Podcast

From Dallas and Hesitant About Clinical Research. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education.

article thumbnail

Ep. 006 – Mark Stinson & Bob Baurys Podcast Transcript

Pharma Marketing Network

Don (PMN): Hi good morning everyone, welcome to the pharma marketing podcast. I’m your host Don Langsdorf and I am here today with Bob Baurys and Mark Stinson from 83Bar and also the authors of patient activation. Bob and Mark thanks for joining us today. Bob (83Bar): Great to be here. Mark (83Bar): Yea thank you. Don (PMN): Wonderful. I think it would help our listeners to know a little bit about you first before we jump into the meat of the interview here.

Doctors 40
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

A CONCISE REVIEW ON LIPOSOMES DRUG DELIVERY SYSTEM

Pharma Tutor

ABOUT AUTHORS. BHANDARI SALONI *, KISHNANI KHUSHBOO, RATHORE KAMAL SINGH . BN College of Pharmacy, Udaipur-Raj. 313001. salonibhandari1996.sb@gmail.com. ABSTRACT. Liposomes are concentric bilayer vesicles, which were first developed by Bangham and his colleagues in 1961. They are highly efficient having high drug entrapment capacity. Due to their size, hydrophobic and lipophilic character they are most widely used vehicles for drug delivery.

article thumbnail

The Royal Society of Chemistry’s Emerging Technologies Competition 2020 welcomes entries

Drug Discovery Today

Competition to bring cutting-edge science to the real world seeks projects to tackle the world’s most pressing issues in extraordinary year

40

More Trending

article thumbnail

Federal Court determines that infringement action under PM(NOC) Regulations is not moot where trial proceeds after patent expiry

Pharma in Brief

On May 22, 2020, the Federal Court granted a motion seeking an order that the issue of infringement in an action brought pursuant to section 6 of the Patented Medicines (Notice of Compliance) Regulations ( Regulations ) would not be moot notwithstanding that the trial was set to proceed after the expiry of the relevant patent. Background. Sandoz served a Notice of Allegation on AstraZeneca alleging non-infringement, invalidity and ineligibility for listing of AstraZeneca’s patent for saxagliptin

article thumbnail

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

Don (PMN): Hi welcome. This is Don Langsdorf with the Pharma Marketing Network pleased to welcome today Dave Chase, co-founder of the Health Rosetta. Good morning, Dave. Thanks for coming on the podcast and if you wouldn’t mind, could tell us a little bit about yourself. Dave (HR): Sure. Thanks for having me on. Quick background on myself. I started my career in consulting implementing systems inside of a couple dozen different hospitals and then I went on to find Microsoft’s healthc

HR 40